XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Cash and cash equivalents:    
Cash and due from banks $ 4,870 $ 6,564
Interest-bearing balances with banks 635,556 391,665
Total cash and cash equivalents 640,426 398,229
Investment securities available-for-sale 349,678 345,275
Equity securities 41,037 41,086
Loans held-for-sale 0 629
Loans receivable 2,267,310 2,317,594
Allowance for credit losses (22,804) (22,124)
Loans receivable, net 2,244,506 2,295,470
Premises and equipment, net 19,968 20,928
Bank-owned life insurance 44,569 44,287
Equity method investments 76,190 75,754
Accrued interest receivable and other assets 131,016 92,224
TOTAL ASSETS 3,547,390 3,313,882
Deposits:    
Noninterest-bearing 1,391,070 1,197,272
Interest-bearing 1,754,259 1,704,204
Total deposits 3,145,329 2,901,476
Accrued interest payable and other liabilities 26,272 37,917
Repurchase agreements 3,810 4,821
Subordinated debt 73,602 73,540
Senior term loan 6,549 6,786
Total liabilities 3,255,562 3,024,540
STOCKHOLDERS’ EQUITY    
Common stock - par value $1; 40,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 13,688,899 and 12,840,883 shares issued and outstanding, respectively, as of March 31, 2024 and 13,606,399 and 12,758,383 shares issued and outstanding, respectively, as of December 31, 2023 13,689 13,606
Additional paid-in capital 162,502 160,488
Retained earnings 163,199 160,862
Accumulated other comprehensive loss (30,799) (28,831)
Treasury stock - 848,016 shares as of March 31, 2024 and December 31, 2023, at cost (16,741) (16,741)
Total equity attributable to parent 291,850 289,384
Noncontrolling interest (22) (42)
Total stockholders' equity 291,828 289,342
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 3,547,390 $ 3,313,882